Kenneth Fleisher, DDS, FACS: No financial relationships to disclose
Bone health and maintenance of bone integrity are important concerns during comprehensive cancer care and management of osteoporosis. Bisphosphonates and denosumab are antiresorptive medications widely used for the prevention and treatment of osteoporosis and skeletal complications associated with metastatic cancer and multiple myeloma. Medication-related osteonecrosis of the jaw (MRONJ) related to antiresorptive therapy is a condition that has created numerous dilemmas in patient management and may have a broad health impact. This case-based presentation will review evidence-based data that has led to paradigm shifts for pathogenesis and innovative strategies for risk assessment, prevention and management of MRONJ.
Learning Objectives:
Describe evidence-based data for risk assessment, diagnosis, and preventive strategies for patients at risk for MRONJ
Demonstrate endodontic management strategies for patients at risk for MRONJ
.jpg)
.jpg "Kenneth Fleisher, D.D.S., FACS photo")